Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

874 ARTÍCULOS , VIENDO DEL 451 AL 465

The effects of transcranial magnetic stimulation in motor symptoms of Parkinson's disease: an overview of systematic reviews with meta-analysis

Conte D, Roman A, Beorchia Y, Pinzini C, Castriotta L, Valente M.

Neurol Sci. 2025 Aug;46(8):3405-3418. doi: 10.1007/s10072-025-08189-5. Epub 2025 Apr 16.

Phase I/II trial of iPS-cell-derived dopaminergic cells for Parkinson's disease

Sawamoto N, Doi D, Nakanishi E, Sawamura M, Kikuchi T, Yamakado H, Taruno Y, Shima A, Fushimi Y, Okada T, Kikuchi T, Morizane A, Hiramatsu S, Anazawa T, Shindo T, Ueno K, Morita S, Arakawa Y, Nakamoto Y, Miyamoto S, Takahashi R, Takahashi J.

Nature. 2025 May;641(8064):971-977. doi: 10.1038/s41586-025-08700-0. Epub 2025 Apr 16.

Phase I trial of hES cell-derived dopaminergic neurons for Parkinson's disease

Tabar V, Sarva H, Lozano AM, Fasano A, Kalia SK, Yu KKH, Brennan C, Ma Y, Peng S, Eidelberg D, Tomishima M, Irion S, Stemple W, Abid N, Lampron A, Studer L, Henchcliffe C.

Nature. 2025 May;641(8064):978-983. doi: 10.1038/s41586-025-08845-y. Epub 2025 Apr 16.

The potential of distributed diagnostics for the early detection of Parkinson's disease

Khanna A, Beck J, Poston K, Schwarzschild MA, Jones GB.

J Parkinsons Dis. 2025 May;15(3):646-653. doi: 10.1177/1877718X251336118. Epub 2025 Apr 17.

Transcutaneous Tibial Nerve Stimulation for Overactive Bladder Symptoms in Parkinson's Disease: Results from a Phase II Randomized Control Trial (STRIPE)

Smith MD, Portlock GE, Cullen A, Nodehi A, Drake MJ, Ben-Shlomo Y, Henderson EJ.

Mov Disord. 2025 Jul;40(7):1291-1296. doi: 10.1002/mds.30186. Epub 2025 Apr 17.

Efficacy and Safety of Magnetic Resonance-Guided Focused Ultrasound Thalamotomy in Essential Tremor: A Systematic Review and Metanalysis

Shiramba A, Lane S, Ray N, Gilbertson T, Srinivasaiah R, Panicker J, Radon M, Osman-Farah J, Macerollo A.

Mov Disord. 2025 Jun;40(6):1020-1033. doi: 10.1002/mds.30188. Epub 2025 Apr 17.

The safety profile of subthalamic nucleus and globus pallidus internus deep brain stimulation for Parkinson's diseases: A systematic review of perioperative complications and psychological impacts

Eliufoo E, Kamuyalo C, Yusheng T, Nyundo A, Yamin L.

Langenbecks Arch Surg. 2025 Apr 17;410(1):131. doi: 10.1007/s00423-025-03674-z.

Validation of the International Parkinson and Movement Disorder Society Non-Motor Symptoms Questionnaire (MDS-NMS-Q)

Weintraub D, Chaudhuri KR, Schrag A, Martinez-Martin P, Rizos A, Mamikonyan E, Gallagher J, Schoen I, Staunton J, Fernandes MP, Rodriguez-Blazquez C.

Mov Disord. 2025 Jun;40(6):1037-1046. doi: 10.1002/mds.30202. Epub 2025 Apr 18.

Efficacy and Safety of Novel Continuous Subcutaneous Levodopa Infusion Therapies ND0612 and ABBV-951 for Parkinson's Disease: A Systematic Review

Fernandes MM, Nogueira LOS, Rabelo ISM, Dallé LDC, Corso AMS, Santos FM, Pinto RASR, Borges V, Ferraz HB, Boone DL.

J Geriatr Psychiatry Neurol. 2025 Sep;38(5):326-338. doi: 10.1177/08919887251335011. Epub 2025 Apr 20.

Molecular-Informed Network Analysis Unveils Fatigue-Related Functional Connectivity in Parkinson's Disease

Di Vico IA, Moretto M, Tamanti A, Tomelleri G, Burati G, Martins D, Dipasquale O, Veronese M, Bertoldo A, Menini E, Sandri A, Ottaviani S, Pizzini FB, Tinazzi M, Castellaro M.

Mov Disord. 2025 Aug;40(8):1561-1571. doi: 10.1002/mds.30214. Epub 2025 Apr 22.

Genetic Risk Factors in Normal Pressure Hydrocephalus: What We Know and What Is Next

Piccinin CC, Anis S, Yu JRT, Salles PA, Chaparro-Solano HM, Kundrick A, Ivary S, Liao JY, Nagel SJ, Mata IF.

Mov Disord. 2025 Jul;40(7):1233-1247. doi: 10.1002/mds.30206. Epub 2025 Apr 23.

Cannabidiol and cognitive functions/inflammatory markers in Parkinson's disease: A double-blind randomized controlled trial at Buriram Hospital (CBD-PD-BRH trial)

Mitarnun W, Kanjanarangsichai A, Junlaor P, Kongngern L, Mitarnun W, Pangwong W, Nonghan P.

Parkinsonism Relat Disord. 2025 Jun;135:107841. doi: 10.1016/j.parkreldis.2025.107841. Epub 2025 Apr 16.

Corticospinal Tract Development, Evolution, and Skilled Movements

Roze E, Dubacq C, Welniarz Q.

Mov Disord. 2025 Jul;40(7):1221-1232. doi: 10.1002/mds.30199. Epub 2025 Apr 25.

Efficacy and safety of glucagon-like peptide 1 agonists for Parkinson's disease: a systematic review and meta-analysis

Nogueira LOS, Mazetto RASV, Defante MLR, Antunes VLJ, Gonçalves OR, Corso AMS, Coletta MVD, Boone DL, Machado Filho WS, Borges V, Ferraz HB.

Arq Neuropsiquiatr. 2025 Apr;83(4):1-10. doi: 10.1055/s-0045-1806824. Epub 2025 Apr 27.

Self-management interventions involving care partners of individuals with neurodegenerative movement disorders: a scoping review

Crozier O, Cimino SR, Alvarez L, Johnson AM, Holmes JD.

Disabil Rehabil. 2025 Dec;47(24):6251-6270. doi: 10.1080/09638288.2025.2496784. Epub 2025 Apr 28.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias